KY Biotechnology & Medical Research

Belite Bio, Inc (BLTE)

Track

Track

Belite Bio experienced significant selling activity over the past ninety days, totaling approximately 71.95 million dollars across fifty-three transactions. Executives, including the CEO and CMO, executed these planned divestments following the August results financiers. Despite this heavy liquidation, the stock price remains near its yearly midpoint, reflecting stable market sentiment ahead of upcoming quarterly disclosures.
Ticker: BLTE Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Belite Bio, Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Planned sale
Price
263.27
Quantity 74,781 -31.8%
Value US$3,709,499
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Planned sale
Price
77.74
Quantity 73,666 -9.8%
Value US$4,332,085
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Planned sale
Price
358.19
Quantity 70,677 -4.8%
Value US$3,612,450
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Planned sale
Price
167.59
Quantity 1,000 -0.5%
Value US$100,000
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Planned sale
Price
166.44
Quantity 1,000 -0.3%
Value US$100,000
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Planned sale
Price
165.49
Quantity 1,000 -0.8%
Value US$100,000
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Planned sale
Price
164.64
Quantity 1,000 -0.2%
Value US$100,000
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Planned sale
Price
163.63
Quantity 1,000 -1.3%
Value US$100,000
1.5
Hendrik Peter Scholl Officer Officer
Transaction date
Proposed sale
Price
169.82
Quantity 1,000
Value US$100,000
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
198.09
Quantity 2,700 -3.7%
Value US$534,845
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
197.36
Quantity 8,752 -10.7%
Value US$1,727,275
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
196.54
Quantity 6,058 -6.9%
Value US$1,190,642
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
195.62
Quantity 6,090 -6.5%
Value US$1,191,325
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
194.33
Quantity 2,400 -2.5%
Value US$466,399
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
198.05
Quantity 2,562 -9.0%
Value US$507,392
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
197.23
Quantity 4,605 -13.9%
Value US$908,244
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
196.47
Quantity 4,475 -11.9%
Value US$879,200
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
195.60
Quantity 4,120 -9.9%
Value US$805,889
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
194.28
Quantity 2,200 -5.0%
Value US$427,414
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
193.13
Quantity 8,111 -7.8%
Value US$1,566,439
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
192.54
Quantity 4,209 -3.9%
Value US$810,412
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
191.15
Quantity 11,080 -9.3%
Value US$2,117,909
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
190.39
Quantity 600 -0.5%
Value US$114,232
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
189.34
Quantity 8,955 -6.9%
Value US$1,695,552
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
188.26
Quantity 3,045 -2.3%
Value US$573,253
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
187.25
Quantity 6,200 -4.5%
Value US$1,160,964
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
186.32
Quantity 7,800 -5.3%
Value US$1,453,323
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
185.34
Quantity 4,593 -3.0%
Value US$851,286
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
184.52
Quantity 6,252 -4.0%
Value US$1,153,647
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
183.30
Quantity 4,955 -3.1%
Value US$908,228
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
182.50
Quantity 3,413 -2.1%
Value US$622,869
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
181.24
Quantity 2,587 -1.5%
Value US$468,877
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
180.29
Quantity 2,635 -1.5%
Value US$475,071
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
193.12
Quantity 4,602 -9.5%
Value US$888,727
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
192.40
Quantity 3,398 -6.5%
Value US$653,788
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
191.09
Quantity 6,200 -10.7%
Value US$1,184,754
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
190.63
Quantity 1,800 -3.0%
Value US$343,140
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
189.22
Quantity 6,200 -9.4%
Value US$1,173,191
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
188.59
Quantity 1,900 -2.8%
Value US$358,318
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
187.16
Quantity 3,900 -5.4%
Value US$729,942
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
186.35
Quantity 4,600 -6.0%
Value US$857,187
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
185.28
Quantity 3,872 -4.8%
Value US$717,408
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
184.57
Quantity 3,569 -4.2%
Value US$658,744
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
183.27
Quantity 3,759 -4.3%
Value US$688,899
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
182.49
Quantity 2,000 -2.2%
Value US$364,985
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
181.05
Quantity 2,000 -2.2%
Value US$362,107
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
180.16
Quantity 1,633 -1.7%
Value US$294,201
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
180.57
Quantity 223 -0.2%
Value US$40,267
Chuang Hao-Yuan Chief Financial Officer Executive Director
Transaction date
Planned sale
Price
180.00
Quantity 144 -0.2%
Value US$25,920
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
180.57
Quantity 223 -0.1%
Value US$40,267
Lin Yu-Hsin Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
180.00
Quantity 142 -0.1%
Value US$25,560
Yu-Hsin Lin CEO, Chairman
Transaction date
Proposed sale
Price
177.58
Quantity 126,800
Value US$22,517,144
Hao-Yuan Chuang Officer, Director Executive Director
Transaction date
Proposed sale
Price
177.58
Quantity 93,800
Value US$16,657,004
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
147.11
Quantity 96 -0.6%
Value US$14,123
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
147.11
Quantity 96 -0.6%
Value US$14,123
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
146.24
Quantity 1,199 -7.4%
Value US$175,348
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
146.24
Quantity 1,199 -7.4%
Value US$175,348
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
145.43
Quantity 4,861 -23.0%
Value US$706,959
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
145.43
Quantity 4,861 -23.0%
Value US$706,959
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
144.66
Quantity 3,748 -15.0%
Value US$542,192
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
144.66
Quantity 3,748 -15.0%
Value US$542,192
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
143.90
Quantity 96 -0.4%
Value US$13,814
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
143.90
Quantity 96 -0.4%
Value US$13,814
1.5
Dr. Hendrick P. Scholl Affiliate
Transaction date
Proposed sale
Price
148.34
Quantity 10,000
Value US$1,483,400
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
145.02
Quantity 1,035 -4.0%
Value US$150,097
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
143.55
Quantity 1,897 -6.8%
Value US$272,314
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
142.20
Quantity 450 -1.6%
Value US$63,988
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
141.83
Quantity 100 -0.4%
Value US$14,183
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
140.58
Quantity 540 -1.9%
Value US$75,915
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
139.57
Quantity 3,140 -9.8%
Value US$438,260
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
138.18
Quantity 784 -2.4%
Value US$108,331
1.5
Scholl Hendrik Peter Chief Medical Officer Officer
Transaction date
Sale
Price
137.61
Quantity 2,054 -5.9%
Value US$282,641
1.5
Dr. Hendrick P. Scholl Affiliate
Transaction date
Proposed sale
Price
144.24
Quantity 10,000
Value US$1,442,400
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
155.25
Quantity 9 -100.0%
Value US$1,397
MATA NATHAN L. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
154.61
Quantity 3 -25.0%
Value US$464
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-05 2026-10-01 PlS Planned sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
74,781 -31.8%
263.27
US$3,709,499 		74,781 -31.8% 263.27 US$3,709,499
2026-10-05 2026-10-01 PlS Planned sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
73,666 -9.8%
77.74
US$4,332,085 		73,666 -9.8% 77.74 US$4,332,085
2026-10-05 2026-10-01 PlS Planned sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
70,677 -4.8%
358.19
US$3,612,450 		70,677 -4.8% 358.19 US$3,612,450
2026-10-05 2026-10-01 PlS Planned sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,000 -0.5%
167.59
US$100,000 		1,000 -0.5% 167.59 US$100,000
2026-10-05 2026-10-01 PlS Planned sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,000 -0.3%
166.44
US$100,000 		1,000 -0.3% 166.44 US$100,000
2026-10-05 2026-10-01 PlS Planned sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,000 -0.8%
165.49
US$100,000 		1,000 -0.8% 165.49 US$100,000
2026-10-05 2026-10-01 PlS Planned sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,000 -0.2%
164.64
US$100,000 		1,000 -0.2% 164.64 US$100,000
2026-10-05 2026-10-01 PlS Planned sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,000 -1.3%
163.63
US$100,000 		1,000 -1.3% 163.63 US$100,000
2026-10-01 2026-10-01 PrS Proposed sale
1.5
Hendrik Peter Scholl

Officer

Officer
1,000
169.82
US$100,000 		1,000 169.82 US$100,000
2026-09-09 2026-09-08 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
2,700 -3.7%
198.09
US$534,845 		2,700 -3.7% 198.09 US$534,845
2026-09-09 2026-09-08 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
8,752 -10.7%
197.36
US$1,727,275 		8,752 -10.7% 197.36 US$1,727,275
2026-09-09 2026-09-08 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
6,058 -6.9%
196.54
US$1,190,642 		6,058 -6.9% 196.54 US$1,190,642
2026-09-09 2026-09-08 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
6,090 -6.5%
195.62
US$1,191,325 		6,090 -6.5% 195.62 US$1,191,325
2026-09-09 2026-09-08 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
2,400 -2.5%
194.33
US$466,399 		2,400 -2.5% 194.33 US$466,399
2026-09-09 2026-09-08 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
2,562 -9.0%
198.05
US$507,392 		2,562 -9.0% 198.05 US$507,392
2026-09-09 2026-09-08 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
4,605 -13.9%
197.23
US$908,244 		4,605 -13.9% 197.23 US$908,244
2026-09-09 2026-09-08 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
4,475 -11.9%
196.47
US$879,200 		4,475 -11.9% 196.47 US$879,200
2026-09-09 2026-09-08 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
4,120 -9.9%
195.60
US$805,889 		4,120 -9.9% 195.60 US$805,889
2026-09-09 2026-09-08 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
2,200 -5.0%
194.28
US$427,414 		2,200 -5.0% 194.28 US$427,414
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
8,111 -7.8%
193.13
US$1,566,439 		8,111 -7.8% 193.13 US$1,566,439
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
4,209 -3.9%
192.54
US$810,412 		4,209 -3.9% 192.54 US$810,412
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
11,080 -9.3%
191.15
US$2,117,909 		11,080 -9.3% 191.15 US$2,117,909
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
600 -0.5%
190.39
US$114,232 		600 -0.5% 190.39 US$114,232
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
8,955 -6.9%
189.34
US$1,695,552 		8,955 -6.9% 189.34 US$1,695,552
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
3,045 -2.3%
188.26
US$573,253 		3,045 -2.3% 188.26 US$573,253
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
6,200 -4.5%
187.25
US$1,160,964 		6,200 -4.5% 187.25 US$1,160,964
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
7,800 -5.3%
186.32
US$1,453,323 		7,800 -5.3% 186.32 US$1,453,323
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
4,593 -3.0%
185.34
US$851,286 		4,593 -3.0% 185.34 US$851,286
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
6,252 -4.0%
184.52
US$1,153,647 		6,252 -4.0% 184.52 US$1,153,647
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
4,955 -3.1%
183.30
US$908,228 		4,955 -3.1% 183.30 US$908,228
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
3,413 -2.1%
182.50
US$622,869 		3,413 -2.1% 182.50 US$622,869
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
2,587 -1.5%
181.24
US$468,877 		2,587 -1.5% 181.24 US$468,877
2026-09-09 2026-09-04 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
2,635 -1.5%
180.29
US$475,071 		2,635 -1.5% 180.29 US$475,071
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
4,602 -9.5%
193.12
US$888,727 		4,602 -9.5% 193.12 US$888,727
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
3,398 -6.5%
192.40
US$653,788 		3,398 -6.5% 192.40 US$653,788
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
6,200 -10.7%
191.09
US$1,184,754 		6,200 -10.7% 191.09 US$1,184,754
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
1,800 -3.0%
190.63
US$343,140 		1,800 -3.0% 190.63 US$343,140
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
6,200 -9.4%
189.22
US$1,173,191 		6,200 -9.4% 189.22 US$1,173,191
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
1,900 -2.8%
188.59
US$358,318 		1,900 -2.8% 188.59 US$358,318
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
3,900 -5.4%
187.16
US$729,942 		3,900 -5.4% 187.16 US$729,942
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
4,600 -6.0%
186.35
US$857,187 		4,600 -6.0% 186.35 US$857,187
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
3,872 -4.8%
185.28
US$717,408 		3,872 -4.8% 185.28 US$717,408
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
3,569 -4.2%
184.57
US$658,744 		3,569 -4.2% 184.57 US$658,744
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
3,759 -4.3%
183.27
US$688,899 		3,759 -4.3% 183.27 US$688,899
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
2,000 -2.2%
182.49
US$364,985 		2,000 -2.2% 182.49 US$364,985
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
2,000 -2.2%
181.05
US$362,107 		2,000 -2.2% 181.05 US$362,107
2026-09-09 2026-09-04 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
1,633 -1.7%
180.16
US$294,201 		1,633 -1.7% 180.16 US$294,201
2026-08-14 2026-08-12 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
223 -0.2%
180.57
US$40,267 		223 -0.2% 180.57 US$40,267
2026-08-14 2026-08-12 PlS Planned sale
Chuang Hao-Yuan

Chief Financial Officer

Executive Director
144 -0.2%
180.00
US$25,920 		144 -0.2% 180.00 US$25,920
2026-08-14 2026-08-12 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
223 -0.1%
180.57
US$40,267 		223 -0.1% 180.57 US$40,267
2026-08-14 2026-08-12 PlS Planned sale
Lin Yu-Hsin

Chief Executive Officer

Executive Director
142 -0.1%
180.00
US$25,560 		142 -0.1% 180.00 US$25,560
2026-08-12 2026-08-12 PrS Proposed sale
Yu-Hsin Lin

CEO, Chairman
126,800
177.58
US$22,517,144 		126,800 177.58 US$22,517,144
2026-08-12 2026-08-12 PrS Proposed sale
Hao-Yuan Chuang

Officer, Director

Executive Director
93,800
177.58
US$16,657,004 		93,800 177.58 US$16,657,004
2026-06-22 2026-06-18 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
96 -0.6%
147.11
US$14,123 		96 -0.6% 147.11 US$14,123
2026-06-22 2026-06-18 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
96 -0.6%
147.11
US$14,123 		96 -0.6% 147.11 US$14,123
2026-06-22 2026-06-18 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,199 -7.4%
146.24
US$175,348 		1,199 -7.4% 146.24 US$175,348
2026-06-22 2026-06-18 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,199 -7.4%
146.24
US$175,348 		1,199 -7.4% 146.24 US$175,348
2026-06-22 2026-06-18 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
4,861 -23.0%
145.43
US$706,959 		4,861 -23.0% 145.43 US$706,959
2026-06-22 2026-06-18 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
4,861 -23.0%
145.43
US$706,959 		4,861 -23.0% 145.43 US$706,959
2026-06-22 2026-06-18 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
3,748 -15.0%
144.66
US$542,192 		3,748 -15.0% 144.66 US$542,192
2026-06-22 2026-06-18 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
3,748 -15.0%
144.66
US$542,192 		3,748 -15.0% 144.66 US$542,192
2026-06-22 2026-06-18 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
96 -0.4%
143.90
US$13,814 		96 -0.4% 143.90 US$13,814
2026-06-22 2026-06-18 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
96 -0.4%
143.90
US$13,814 		96 -0.4% 143.90 US$13,814
2026-06-18 2026-06-18 PrS Proposed sale
1.5
Dr. Hendrick P. Scholl

Affiliate
10,000
148.34
US$1,483,400 		10,000 148.34 US$1,483,400
2026-06-17 2026-06-16 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,035 -4.0%
145.02
US$150,097 		1,035 -4.0% 145.02 US$150,097
2026-06-17 2026-06-16 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,897 -6.8%
143.55
US$272,314 		1,897 -6.8% 143.55 US$272,314
2026-06-17 2026-06-16 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
450 -1.6%
142.20
US$63,988 		450 -1.6% 142.20 US$63,988
2026-06-17 2026-06-16 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
100 -0.4%
141.83
US$14,183 		100 -0.4% 141.83 US$14,183
2026-06-17 2026-06-16 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
540 -1.9%
140.58
US$75,915 		540 -1.9% 140.58 US$75,915
2026-06-17 2026-06-16 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
3,140 -9.8%
139.57
US$438,260 		3,140 -9.8% 139.57 US$438,260
2026-06-17 2026-06-16 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
784 -2.4%
138.18
US$108,331 		784 -2.4% 138.18 US$108,331
2026-06-17 2026-06-16 S Sale
1.5
Scholl Hendrik Peter

Chief Medical Officer

Officer
2,054 -5.9%
137.61
US$282,641 		2,054 -5.9% 137.61 US$282,641
2026-06-16 2026-06-16 PrS Proposed sale
1.5
Dr. Hendrick P. Scholl

Affiliate
10,000
144.24
US$1,442,400 		10,000 144.24 US$1,442,400
2026-05-08 2026-05-07 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
9 -100.0%
155.25
US$1,397 		9 -100.0% 155.25 US$1,397
2026-05-08 2026-05-07 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
3 -25.0%
154.61
US$464 		3 -25.0% 154.61 US$464
Explore more

More insider trading research around Belite Bio, Inc

More insider trades in KY
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity